Putative malignant hyperthermia mutation Ca(V)1.1-R174W is insufficient to trigger a fulminant response to halothane or confer heat stress intolerance

Malignant hyperthermia susceptibility (MHS) is an autosomal dominant pharmacogenetic disorder that manifests as a hypermetabolic state when carriers are exposed to halogenated volatile anesthetics or depolarizing muscle relaxants. In animals, heat stress intolerance is also observed. MHS is linked t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wei, Lopez, Jose R., Antrobus, Shane, Zheng, Jing, Uryash, Arkady, Dong, Yao, Beqollari, Donald, Bannister, Roger A., Hopkins, Philip M., Beam, Kurt G., Allen, Paul D., Pessah, Isaac.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413282/
https://www.ncbi.nlm.nih.gov/pubmed/37392848
http://dx.doi.org/10.1016/j.jbc.2023.104992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413282/
https://www.ncbi.nlm.nih.gov/pubmed/37392848
http://dx.doi.org/10.1016/j.jbc.2023.104992

Ejemplares similares